C M Bidwell & Associates LTD Medpace Holdings, Inc. Transaction History

C M Bidwell & Associates LTD

$189 Million
Q2 2025

A detailed history of C M Bidwell & Associates LTD transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, C M Bidwell & Associates LTD holds 201 shares of MEDP stock, worth $109,426. This represents 0.03% of its overall portfolio holdings.

Number of Shares

201

Previous 201 -0.0%

Holding current value

$109,426

Previous $61,000 3.28%

% of portfolio

0.03%

Previous 0.04%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$304.69 - $360.97 $2,132 - $2,526	-7 Reduced 3.37%	201 $61,000
Q3 2024 Nov 13, 2024	SELL	$320.58 - $457.29 $11,861 - $16,919	-37 Reduced 15.1%	208 $69,000
Q1 2024 May 13, 2024	BUY	$284.87 - $413.31 $24,498 - $35,544	86 Added 54.09%	245 $99,000
Q2 2023 Aug 11, 2023	BUY	$187.26 - $240.17 $29,774 - $38,187	159 New	159 $38,000
Q2 2021 Aug 13, 2021	SELL	$158.62 - $194.3 $64,399 - $78,885	-406 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$132.02 - $168.26 $2,640 - $3,365	-20 Reduced 4.69%	406 $67,000
Q4 2020 Feb 16, 2021	SELL	$109.38 - $149.19 $10,719 - $14,620	-98 Reduced 18.7%	426 $59,000
Q3 2020 Nov 13, 2020	SELL	$92.95 - $130.61 $15,894 - $22,334	-171 Reduced 24.6%	524 $59,000
Q2 2020 Aug 14, 2020	SELL	$68.08 - $95.68 $178,029 - $250,203	-2,615 Reduced 79.0%	695 $65,000
Q1 2020 May 15, 2020	BUY	$61.71 - $101.95 $154,275 - $254,875	2,500 Added 308.64%	3,310 $243,000
Q4 2019 Feb 12, 2020	SELL	$70.08 - $84.64 $64,123 - $77,445	-915 Reduced 53.04%	810 $68,000
Q3 2019 Nov 13, 2019	BUY	$62.38 - $85.89 $107,605 - $148,160	1,725 New	1,725 $145,000

Others Institutions Holding MEDP

# of Institutions

660

Shares Held

27M

Call Options Held

53.6K

Put Options Held

108K

View Full List

About Medpace Holdings, Inc.

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $16.9B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

More about MEDP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on C M Bidwell & Associates LTD with notifications on news.

Account

C M Bidwell & Associates LTD Medpace Holdings, Inc. Transaction History